Alivus Life Sciences Board Meeting for Q2 FY2027 Results
Earnings & Results
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
21st Oct 2026
Key Dates and Events
- Board of Directors meeting scheduled for Thursday, October 29, 2026
- Meeting agenda includes consideration and approval of Unaudited Financial Results for the quarter and half year ended September 30, 2026
- Trading window closure period: October 1, 2026 to October 31, 2026 (both days inclusive)
Regulatory Compliance Details
- Disclosure made under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Trading window closure implemented pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
- Closure applies to all 'designated persons' as defined under the company's Code of Conduct for Prevention of Insider Trading
Corporate Addresses
- Corporate Office: Technopolis Knowledge Park, A wing, Office No. 401 to 407, 4th Floor, Mahakali Caves Road, Andheri (E), Mumbai – 400093
- Contact: T: +91 22 6829 7979 | E: complianceofficer@alivus.com | W: www.alivus.com